Phosphatidylserine Supplemented Food Caution Box Review for Canadian Buyers

Canadian phosphatidylserine projects often move smoothly through sourcing, specification review, and route selection, then stall when artwork starts. The question looks simple: does this label need a caution box, and if so, what exactly triggers it?

The short answer is that if the project is using the current Canadian supplemented-food route for phosphatidylserine (soy), the buyer should not treat the caution box as optional. Health Canada's public entry permits phosphatidylserine (soy) in foods belonging to permitted supplemented-food categories up to 300 mg per serving, requires baseline cautionary statements for all products, and adds a serving-limit statement once the declared amount is more than 60 mg per serving. The same public materials also make another practical point clear: the route is currently written for phosphatidylserine made from food grade soy lecithin, not for every phosphatidylserine source or characterization.

This article is written for importers, distributors, functional food brands, procurement managers, formulation teams, QA teams, and regulatory reviewers serving Canada. It focuses on label-preparation workflow and buyer-side document control. It does not provide legal advice and it does not make medical treatment claims.

Where Nutranexa is mentioned, only verified public facts are used. Nutranexa identifies the operating company as Shandong Baianrui Biopharmaceutical Co., Ltd., founded in 2013, operating a 110,000+ m2 campus, and primarily serving Europe and North America. The site keeps Phosphatidylserine, Soja Phosphatidylserine, and Girassol Phosphatidylserine on separate buyer paths and provides request paths for current specifications, COA support, Qualidade e P&D, and Contato de vendas.

The Short Answer Canadian Buyers Need First

If your team is preparing a Canadian supplemented-food label with phosphatidylserine, review the caution box as a route-specific compliance checkpoint, not a late-stage artwork detail.

For buyer teams, the minimum workable process is:

1. Confirm the project is actually a Canada supplemented-food route and that the ingredient under review is the current soy characterization.
2. Confirm the declared phosphatidylserine amount per serving and the intended number of servings per day.
3. Review the label as one system: Supplemented Food Facts, caution box, front-of-pack identifier, bilingual wording, and any market-facing product description.
4. Keep route selection, supplier qualification, and claim review separate from the caution-box decision.
5. Close the file with one explicit go, hold, or escalate note before packaging artwork or customer approval continues.

Why This Caution-Box Review Is Its Own Buyer Task

The current public food route is soy-specific, not generic PS

The first reason this question deserves its own article is that the public Canadian food route is not written as a broad phosphatidylserine permission. Health Canada's modification notice and current List of Permitted Supplemental Ingredients describe phosphatidylserine (soy), permit it in foods belonging to a listed supplemented-food category, cap it at 300 mg per serving, and identify the ingredient as phosphatidylserine made from food grade soy lecithin.

That is a direct buyer-control issue. If procurement is comparing general phosphatidylserine, soy phosphatidylserine, and sunflower phosphatidylserine as if they all sit under the same Canadian food entry, the label review is already unstable. The earlier Canada route-selection article helps teams decide whether the project belongs in an NHP or supplemented-food path. This article starts one step later, after that route decision is already made.

Health Canada's safety summary reinforces that boundary. It explains that phosphatidylserine derived from soy was the subject of the safety assessment and says stakeholders seeking future changes outside the current characterization should submit a pre-market request. The practical implication is an inference from those primary sources: if the project is not the current soy route, the buyer should escalate the route question before anyone finalizes the caution box or serves-per-day language.

Caution box, Supplemented Food Facts, and bilingual review are separate checkpoints

The second reason this question matters is that Canadian teams often compress several different label tasks into one phrase like "Canada warning text." That shortcut creates rework.

Health Canada's supplemented-food labels page explains that some supplemented foods must carry a caution box on the back or side of the label, grouped under a standardized Caution heading, and that products with one or more cautionary statements can also require the front-of-pack supplemented-food caution identifier. CFIA's supplemented-food labelling page separately points buyers to the required Supplemented Food Facts table formats and to the incorporated documents that control label presentation. CFIA's bilingual food-labelling guidance then adds another practical distinction: mandatory information on consumer prepackaged foods is generally required in both English and French, while certain shipping containers destined to commercial or industrial enterprises are generally exempt from bilingual labelling.

In buyer terms, that means the team should stop asking only, "what warning sentence goes in the file?" The real questions are:

• Is this a consumer-facing supplemented-food pack or a non-retail shipping container?
• Does the declared phosphatidylserine amount trigger the extra serving-limit statement?
• Does the final consumer pack need the supplemented-food caution identifier on the front panel?
• Is the artwork using a compliant supplemented-food table format and bilingual mandatory wording?

Those checkpoints interact, but they are not interchangeable.

The Five-Part Workflow for Reviewing a Canada PS Caution Box

1. Lock the exact route and food format before artwork starts

Before reviewing a single label line, write down the exact project being evaluated.

At minimum, the note should state:

• that the downstream route is a supplemented food, not an NHP
• the exact ingredient route being quoted, especially whether it is phosphatidylserine (soy)
• the intended food format and serving concept
• whether the current review is for internal regulatory clearance, customer approval, or print-ready artwork

This matters because Canada review can drift quickly. One team may still be using a general "PS powder" description while another has already assumed a soy-route food entry and a third is building bilingual artwork. Once that happens, the caution-box decision no longer belongs to one stable item.

2. Calculate the per-serving and per-day logic before choosing the statements

The next step is the one buyers most often skip: convert the intended declaration into the actual caution-box outcome.

Health Canada's current entry for phosphatidylserine (soy) sets a maximum of 300 mg per serving. It also says that every product using that entry carries the baseline cautionary statements, and that products declaring more than 60 mg per serving must also include a serving-limit statement that keeps the declared daily amount at or below 300 mg.

That creates a practical label-review table:

The serving-limit statement depends on the declared amount on the label, not on a vague product concept. If the marketing brief says 100 mg per serving, or 150 mg per serving, someone needs to calculate how many servings per day fit the 300 mg daily ceiling before the artwork team writes anything.

3. Build the full label architecture, not just one warning sentence

Once the amount logic is stable, review the whole label structure together.

CFIA's supplemented-food labelling page says supplemented foods are subject to Division 29 of the Food and Drug Regulations and to incorporated documents that govern the supplemented-food caution identifier, the Supplemented Food Facts table, permitted food categories, and the supplemental ingredients list. Health Canada's labels page explains that when cautionary statements are required, they must be grouped together under a standardized caution heading, and that the caution identifier on the front panel tells consumers to look for the caution box elsewhere on the label.

For buyers, the operational lesson is straightforward: a compliant Canada file is not just one paragraph of caution text. It is a label architecture that normally includes:

• the correct supplemented-food route for the exact ingredient
• a compliant Supplemented Food Facts table
• the required cautionary statements grouped together in the caution box
• the front-of-pack supplemented-food caution identifier when cautionary statements are required
• consistent product identity and ingredient-route wording across the label and supplier file

This is also why a phosphatidylserine supplier file should not be treated as a final artwork file. The supplier can support the route review with the current specification path, COA style, source identity, and commercial pack details, but the Canadian buyer still has to translate that information into the final food label structure.

Need a Current Canada Label-Review File?

If your team has already chosen the supplemented-food route but is still missing the exact soy-route specification path, source confirmation, or current commercial details needed to finish artwork, pause before the label is frozen. Request the current route-specific document set through Documentos para PS Ingredientes or Contato de vendas and align it to the exact serving concept being reviewed.

4. Keep bilingual review and shipping-container exemptions in the right lane

The next failure point is language scope.

CFIA's bilingual food-labelling guidance states that mandatory information on consumer prepackaged food must generally appear in both English and French. The same page explains that shipping containers destined to a commercial or industrial enterprise are generally exempt from bilingual labelling if they are not resold to consumers at retail and if the mandatory information for shipping containers is provided in one official language.

That distinction matters because phosphatidylserine projects often involve both ingredient containers and finished consumer-facing packs. A raw-material drum shipped to a contract packer is not reviewed the same way as a ready-for-retail supplemented food can, pouch, or bar. Keep ingredient-container review separate from finished consumer-pack review, and do not assume a shipping-container exemption solves the final caution-box requirement.

5. Close the file with one clear Canada decision and no health-claim shortcut

The last step is to close the review in a way another department can actually use.

Health Canada's modification notice says the Food Directorate assessed the ingredient for safe use as a supplemental ingredient in foods, but did not assess efficacy for any purported food health benefit. That is a crucial buyer reminder. A compliant caution box does not mean the food can automatically carry any desired brain-health or function claim. Keep claim review separate.

The closeout note should still end with one clear status:

• Go: the route is the current soy characterization, the declared amount fits the public entry, and the label structure can move forward.
• Hold: the amount logic, bilingual wording, or label architecture is still incomplete.
• Escalate: the project sits outside the current soy-route public entry, exceeds the current maximums, or is trying to convert a food safety assessment into automatic claim approval.

Common Mistakes in Canada PS Caution-Box Review

Most failures are workflow failures:

1. Treating the current Canadian food route as if it applied automatically to every phosphatidylserine source.
2. Forgetting that the extra serving-limit statement is triggered once the declared amount is more than 60 mg per serving.
3. Reviewing a caution box without checking the Supplemented Food Facts table and front-of-pack caution identifier requirements.
4. Assuming a one-language ingredient container proves the final consumer pack can remain unilingual.
5. Treating a food safety entry as if it automatically authorizes any food health claim the brand wants to make.

How Verified Nutranexa Facts Fit This Workflow

For buyers evaluating Nutranexa, several verified public facts support a cleaner Canada label review. The site keeps general phosphatidylserine, soy phosphatidylserine, and sunflower phosphatidylserine on separate product paths, provides visible specification and COA evidence paths, and gives buyers Fabricação e Qualidade e P&D follow-up routes for current documents.

Nutranexa's public commercial baselines also help teams keep the label file tied to a real item while the review is still open: the company states a 2013 founding date, a 110.000+ m2 campus, a primary export focus on Europe and North America, and a PS baseline of 25 kg MOQ with 25 kg líquidos por tambor packaging. Those facts can support planning and supplier screening, but they do not replace the Canada caution-box logic described in this article.

Fontes

• Health Canada: List of Permitted Supplemental Ingredients
• Health Canada: Modification to the List of permitted supplemental ingredients to enable the use of phosphatidylserine (soy)
• Health Canada: Summary of Health Canada's safety assessment of phosphatidylserine for use as a supplemental ingredient
• Health Canada: Supplemented foods labels
• Health Canada: Guidance document for Supplemented Foods Regulations
• Canadian Food Inspection Agency: Labelling requirements for supplemented foods
• Canadian Food Inspection Agency: Bilingual food labelling

Perguntas frequentes

Does every Canadian phosphatidylserine supplemented food need a caution box?

If the project is using the current public phosphatidylserine (soy) supplemented-food entry, buyers should expect the required baseline cautionary statements to be part of the label review. They should also confirm whether the finished consumer pack needs the front-of-pack supplemented-food caution identifier and the correct supplemented-food table format.

When does the extra servings-per-day caution statement apply?

It applies when the declared amount of phosphatidylserine (soy) is more than 60 mg per serving. The wording then has to limit the number of servings per day so the declared daily amount does not exceed 300 mg.

Can a sunflower phosphatidylserine project use the same Canada supplemented-food route automatically?

Buyers should not assume that. Health Canada's current public supplemented-food entry is written for phosphatidylserine (soy) made from food grade soy lecithin. A different source or characterization should be escalated before artwork is approved.

Does a supplier specification or COA decide the Canada caution-box outcome by itself?

No. Those files can support the review, but the caution-box result depends on the Canada route, the declared amount per serving, the final label structure, and the consumer-pack context.

Does the current Canada food entry also approve food health claims for phosphatidylserine?

No. Health Canada's modification notice says the ingredient's efficacy for any purported food health benefit was not evaluated. Buyers should keep claim review separate from the supplemented-food safety and caution-box review.

Contact Sales for Canada Supplemented-Food Support

If your team needs current soy-route phosphatidylserine specifications, source confirmation, document support for Canada supplemented-food artwork, or commercial details tied to the exact serving concept under review, use Contato de vendas. Include the ingredient route, intended food format, declared amount per serving, and current review stage.

Conclusion

Phosphatidylserine caution-box review in Canada becomes manageable when buyers stop treating it as a copywriting task and start treating it as a route-controlled commercialization decision.

The strongest workflow is practical: confirm the supplemented-food path first, confirm that the route is the current soy characterization, calculate the declared amount against the 60 mg per serving e 300 mg per day logic, review the full label architecture instead of one warning sentence, and keep claims separate from the food safety entry. That approach helps procurement, QA, formulation, packaging, and regulatory teams move the same Canadian project forward with the same answer.

Próximas etapas recomendadas

• Revise o Phosphatidylserine página do produto.
• Comparar Soy PS e Sunflower PS.
• Verifique prova de fabricação e Qualidade e P&D.